DE3382156D1 - Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln. - Google Patents

Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln.

Info

Publication number
DE3382156D1
DE3382156D1 DE8383306791T DE3382156T DE3382156D1 DE 3382156 D1 DE3382156 D1 DE 3382156D1 DE 8383306791 T DE8383306791 T DE 8383306791T DE 3382156 T DE3382156 T DE 3382156T DE 3382156 D1 DE3382156 D1 DE 3382156D1
Authority
DE
Germany
Prior art keywords
production
compositions containing
medicinal products
guanosine derivatives
substituted guanosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8383306791T
Other languages
German (de)
English (en)
Inventor
Michael G Goodman
William O Weigle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/439,846 external-priority patent/US4539205A/en
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Application granted granted Critical
Publication of DE3382156D1 publication Critical patent/DE3382156D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8383306791T 1982-11-09 1983-11-08 Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln. Expired - Lifetime DE3382156D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/439,846 US4539205A (en) 1982-11-09 1982-11-09 Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US06/546,679 US4643992A (en) 1982-11-09 1983-11-01 Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives

Publications (1)

Publication Number Publication Date
DE3382156D1 true DE3382156D1 (de) 1991-03-14

Family

ID=27032191

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383306791T Expired - Lifetime DE3382156D1 (de) 1982-11-09 1983-11-08 Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln.

Country Status (15)

Country Link
US (1) US4643992A (enExample)
EP (1) EP0112632B1 (enExample)
AU (1) AU568325B2 (enExample)
CA (1) CA1236401A (enExample)
DE (1) DE3382156D1 (enExample)
DK (1) DK167898B1 (enExample)
ES (1) ES527138A0 (enExample)
FI (1) FI87733C (enExample)
GR (1) GR78733B (enExample)
IE (1) IE56701B1 (enExample)
IL (1) IL70164A (enExample)
NO (1) NO174215C (enExample)
NZ (1) NZ206208A (enExample)
PT (1) PT77636B (enExample)
WO (1) WO1984001898A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5476659A (en) * 1982-11-09 1995-12-19 The Scripps Research Institute Cancerous B cell treatment using substituted nucleoside derivatives
US5093318A (en) * 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US4900675A (en) * 1983-11-01 1990-02-13 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-β-aldoglycosidyl) derivatives
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
ZA869297B (en) * 1985-12-13 1987-11-25 Scripps Clinic Res Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl)derivatives
US7307166B1 (en) 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
US4880784A (en) * 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US4902985A (en) * 1988-02-25 1990-02-20 Raytheon Company Microwave reflectiion amplifiers having increased bandwidth
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
ZA893063B (en) * 1988-04-27 1990-01-31 Immunomedics Inc Improved radiotherapy
AU5845594A (en) * 1992-11-13 1994-06-08 Scripps Research Institute, The Cancerous b cell treatment using substituted nucleoside derivatives
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6562801B1 (en) * 1999-04-15 2003-05-13 Board Of Regents, The University Of Texas System PpGpp and pppGpp as immunomodulatory agents
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20040191214A1 (en) * 2001-06-15 2004-09-30 Johnson Lau Nucleoside vaccine adjuvants
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
KR20060096415A (ko) * 2003-09-05 2006-09-11 애나디스 파마슈티칼스, 인코포레이티드 Ｃ형 간염 바이러스에 의한 감염증을 치료하기 위해투여하는 ｔｌｒ７ 리간드 및 이의 전구약물
MX2007007263A (es) 2004-12-17 2007-08-14 Anadys Pharmaceuticals Inc Compuestos de 3h-oxazolo y 3h-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos, y profarmacos de los mismos.
BRPI0618789A2 (pt) 2005-11-21 2016-08-30 Anadys Pharmaceuticals Inc processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona
TWI418561B (zh) * 2006-06-22 2013-12-11 Anadys Pharmaceuticals Inc ５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
DE602007012881D1 (en) 2006-07-18 2011-04-14 Anadys Pharmaceuticals Inc Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
US8747861B2 (en) * 2007-08-02 2014-06-10 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
WO2009073179A2 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
EP2356225A1 (en) 2008-12-03 2011-08-17 Protea Vaccine Technologies Ltd. GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
SI2364314T1 (sl) 2008-12-09 2014-07-31 Gilead Sciences, Inc. Modulatorji Tollu podobnih receptorjev
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
WO2012114323A1 (en) 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
ES2702278T3 (es) 2012-04-01 2019-02-28 Technion Res & Dev Foundation Péptidos de inductor de metaloproteinasa de matriz extracelular (emmprin) y anticuerpos de unión
AU2015242154B2 (en) 2014-04-03 2019-04-04 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
PL3166607T3 (pl) 2014-07-11 2023-02-20 Gilead Sciences, Inc. Modulatory receptorów toll-podobnych do leczenia hiv
US9738646B2 (en) 2014-09-16 2017-08-22 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1174077A (en) * 1967-02-18 1969-12-10 Ajinomoto Kk Process for Preparing 8-Mercaptopurine Derivatives

Also Published As

Publication number Publication date
NO842765L (no) 1984-07-06
PT77636A (en) 1983-12-01
EP0112632B1 (en) 1991-02-06
FI87733B (fi) 1992-11-13
DK167898B1 (da) 1994-01-03
FI842748A0 (fi) 1984-07-09
DK334884D0 (da) 1984-07-06
FI87733C (fi) 1993-02-25
ES8601301A1 (es) 1985-11-01
IE56701B1 (en) 1991-11-06
AU568325B2 (en) 1987-12-24
NO174215C (no) 1994-03-30
EP0112632A3 (en) 1985-01-23
US4643992A (en) 1987-02-17
NO174215B (no) 1993-12-20
CA1236401A (en) 1988-05-10
DK334884A (da) 1984-07-06
GR78733B (enExample) 1984-10-02
AU2330284A (en) 1984-06-04
IL70164A (en) 1988-06-30
EP0112632A2 (en) 1984-07-04
FI842748L (fi) 1984-07-09
IL70164A0 (en) 1984-02-29
NZ206208A (en) 1987-03-31
WO1984001898A1 (en) 1984-05-24
ES527138A0 (es) 1985-11-01
IE832605L (en) 1984-05-09
PT77636B (en) 1986-03-19

Similar Documents

Publication Publication Date Title
DE3382156D1 (de) Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln.
ATE102181T1 (de) Zwischenprodukte zur herstellung von 1,2,4triazolo(1,5-a>pyrimidin-2-sulfonamiden.
ATE20238T1 (de) Verfahren zur herstellung von ganglioside derivaten und ihre verwendung in pharmaceutischen zusammensetzungen.
DE3483652D1 (de) Zwischenprodukte zur herstellung von dopamin-beta-hydroxylase inhibitoren.
IL64345A (en) Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same
DE3584568D1 (de) Zusammensetzung zur herstellung von backwaren.
ATA54881A (de) Kettengewirkte rohware zur herstellung von hoeschen
ATE8261T1 (de) Verfahren zur herstellung von 3-jodmethylcephalosporinen.
DE3884870D1 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
ATE71104T1 (de) Neues verfahren zur herstellung von sphingosinderivaten.
DE3486277D1 (de) Verfahren zur Herstellung von Riboflavin.
ATE4898T1 (de) Verfahren zur herstellung von 2-chlor-4substituierten 5-thiazolcarboxylaten.
PT70398A (de) Verfahren zur herstellung von 1,2,3-thiadiazol-5-yl-harnstoffen
ATE9897T1 (de) Verfahren zur herstellung von fluorenderivaten.
LU81643A1 (de) Verfahren zur herstellung von aminarmen nahrungsmittel,genussmitteln und futtermitteln
ATE17578T1 (de) Verfahren zur herstellung von furanderivaten.
FI892912A0 (fi) Komposition foer framstaellning av artificiella stenmaterialier.
ZW16182A1 (en) Novel phenoxyphenylamino acid derivatives the production thereof compositions containing them and use thereof
IT1142917B (it) Procedimento per la produzione di articoli di stampa
DD134522A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
ATE60712T1 (de) Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln.
DE3850236D1 (de) Verfahren zur Herstellung von 1-Acyl-2-pyrazolin-Derivaten.
PT73413B (en) Process for the preparation of ergolin derivatives with pharmaceutical effect
PT70178A (de) Verfahren zur herstellung von 1,2,3-thiadiazol-5-yl-harnstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition